skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Understand the latest Corporate Strategies of the biggest Generics and Biosimilar players.

Get an inside view into the corporate strategies of generics’ biggest players with articles like: 
  • Teva Takes A Further Hit On Value Of Actavis
  • Slowing Biopharmaceuticals Puts A Dent In Sandoz’ Sales
  • Wait For Strategic Decisions Weighs Heavily On Mylan
  • If Amneal Goes Global Again, It Intends To Go Big
Corporate Strategies of the biggest Generics and Biosimilar players





電話:+81 (0)3 6273 4260